Bumper Offer - Urjas oil Just @ Rs. 1
Safelevo is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Urinary Tract Infection, Prostatitis, Pneumonia. Secondary and off-label uses of Safelevo have also been mentioned below.
The right dosage of Safelevo depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Safelevo side effects, there are can be others also. These have been listed below. These side effects of Safelevo are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Safelevo's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Safelevo related warnings talks about Safelevo's effects on the liver, heart and kidney.
Safelevo can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Safelevo in conditions like Coronary Artery Disease (CAD), Heart Disease, Myasthenia Gravis (MG). Other conditions have been mentioned below in the Safelevo contraindications section.
Drug interactions for Safelevo have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Safelevo is considered not safe while driving, and is not addictive.
Safelevo is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Safelevo is used -
Severe
Moderate
Mild
Is the use of Safelevo safe for pregnant women?
Safelevo can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Safelevo right away. Take your doctor's advice before taking it again.
Is the use of Safelevo safe during breastfeeding?
Safelevo may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Safelevo on the Kidneys?
Safelevo rarely affects the kidneys.
What is the effect of Safelevo on the Liver?
Safelevo is completely safe for the liver.
What is the effect of Safelevo on the Heart?
Safelevo is not harmful for the heart.
Safelevo should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Safelevo unless your doctor advises you to do so -
Is this Safelevo habit forming or addictive?
No, you will not get addicted to Safelevo.
Is it safe to drive or operate heavy machinery when consuming?
After taking Safelevo you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Safelevo only on doctor's advice.
Is it able to treat mental disorders?
No, Safelevo is not used to treat mental disorders.
Interaction between Food and Safelevo
Taking Safelevo with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Safelevo
Taking Safelevo and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399